What systemic steroid regimen is described for moderateto-severe exacerbations not improved with bronchodilators in asthma and COPD?

What systemic steroid regimen is described for moderateto-severe exacerbations not improved with bronchodilators in asthma and COPD?

• A. 125 mg IV Solumedrol upfront followed by PO prednisone 40 mg daily
• B. Dexamethasone 8 mg IV or PO
• C. Methylprednisolone 500 mg IV
• D. Hydrocortisone 100 mg IV

Answer: (A)

When a moderate-to-severe asthma or COPD flare doesn’t respond to bronchodilators, systemic corticosteroids are used to rapidly quell airway inflammation, improve airflow, and shorten recovery and hospital stay. The best-described approach starts with a high-dose intravenous methylprednisolone given upfront to achieve quick anti-inflammatory effect, especially if oral intake is compromised or rapid action is needed. Then, the patient is switched to an oral corticosteroid, prednisone, at about 40 mg daily to maintain anti-inflammatory support through a short course. This combination provides fast, potent initial control and then convenient, effective continuation with an oral dose, typically for several days, with the aim of resolving the exacerbation efficiently. Other regimens with lower potency or different steroids exist in various settings, but the IV methylprednisolone 125 mg upfront followed by prednisone 40 mg daily reflects the standard, evidence-supported approach for these acute exacerbations.

When a moderate-to-severe asthma or COPD flare doesn’t respond to bronchodilators, systemic corticosteroids are used to rapidly quell airway inflammation, improve airflow, and shorten recovery and hospital stay. The best-described approach starts with a high-dose intravenous methylprednisolone given upfront to achieve quick anti-inflammatory effect, especially if oral intake is compromised or rapid action is needed. Then, the patient is switched to an oral corticosteroid, prednisone, at about 40 mg daily to maintain anti-inflammatory support through a short course.

This combination provides fast, potent initial control and then convenient, effective continuation with an oral dose, typically for several days, with the aim of resolving the exacerbation efficiently. Other regimens with lower potency or different steroids exist in various settings, but the IV methylprednisolone 125 mg upfront followed by prednisone 40 mg daily reflects the standard, evidence-supported approach for these acute exacerbations.